The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer

Resistance to endocrine therapy is common among breast cancer patients with estrogen receptor alpha-positive (ER+) tumors and limits the success of this therapeutic strategy. While the mechanisms that regulate endocrine responsiveness and cell fate are not fully understood, interferon regulatory fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, J. L., Shajahan, A. N., Clarke, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262563/
https://www.ncbi.nlm.nih.gov/pubmed/22295238
http://dx.doi.org/10.4061/2011/912102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262563/
https://www.ncbi.nlm.nih.gov/pubmed/22295238
http://dx.doi.org/10.4061/2011/912102

Ejemplares similares